HAAS JASON enters ODYSSEY THERAPEUTICS, INC. with 61.91K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 5/8/2026ACC: 0001193125-26-212840
Officer· Chief Financial Officer
Since May 2026
61.91K
Baseline shares
100% direct
61.91K
Direct ownership
1 position
284.31K
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned61.91K
Total
61.91K direct61.91K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 61.91K | Direct |
| Total | 61.91K | 61.91K direct |
Derivative Holdings3
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
43.82K
Shares owned
N/A
Exercise price
4.18
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
128.22K
Shares owned
N/A
Exercise price
3.98
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
112.28K
Shares owned
N/A
Exercise price
4.18
Expiration
—
Exercise window
—
Total
Underlying
284.31K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 4.18 | — | — | 43.82K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.98 | — | — | 128.22K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 4.18 | — | — | 112.28K | N/A |
| Total | 284.31K | 0.00 | ||||